Gardasil Approval History
FDA Approved: Yes (First approved June 8, 2006)
Brand name: Gardasil
Generic name: human papillomavirus quadrivalent (types 6, 11, 16, and 18) vaccine, recombinant
Dosage form: Injection
Company: Merck & Co., Inc.
Treatment for: Human Papillomavirus Prophylaxis
Gardasil (human papillomavirus vaccine) is a recombinant vaccine indicated for the prevention of cervical, vulvar, and vaginal cancers caused by human papillomavirus (HPV) in girls and women 9 through 26 years of age. Gardasil is also approved for the prevention of genital warts caused by HPV types 6 and 11 in boys and men 9 through 26 years of age.
Development History and FDA Approval Process for Gardasil
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.